Literature DB >> 8206119

Inhibition by topiramate of seizures in spontaneously epileptic rats and DBA/2 mice.

J Nakamura1, S Tamura, T Kanda, A Ishii, K Ishihara, T Serikawa, J Yamada, M Sasa.   

Abstract

The effects of topiramate, a novel antiepileptic drug, on tonic and absence-like seizures in spontaneously epileptic rats (SER; zi/zi, tm/tm) and on sound-induced seizures in DBA/2 mice were investigated. Topiramate (20 and 40 mg/kg i.p.) inhibited both tonic and absence-like seizures in a dose-dependent manner, whereas phenytoin (20 mg/kg i.p.) and zonisamide (40 mg/kg i.p.) inhibited only the tonic seizures. The inhibitory effects of topiramate on absence-like seizures were antagonized by pretreatment with haloperidol (0.5 mg/kg i.p.), but those on the tonic seizures remained unaffected. Topiramate inhibited sound-induced seizures in DBA/2 mice (ED50 = 8.6 mg/kg p.o.). These findings suggest that topiramate may be effective for treatment of both convulsive and absence seizures of human epilepsy. The inhibitory effect of topiramate on absence-like seizures in SER may be mediated through the central dopaminergic system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206119     DOI: 10.1016/0014-2999(94)90373-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

Review 1.  Topiramate. Clinical profile in epilepsy.

Authors:  R C Sachdeo
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

2.  Topiramate-antagonism of L-glutamate-induced paroxysms in planarians.

Authors:  Robert B Raffa; Kristin E Finno; Christopher S Tallarida; Scott M Rawls
Journal:  Eur J Pharmacol       Date:  2010-09-19       Impact factor: 4.432

3.  Failure of ischemic neuroprotection by potentiators of gamma-aminobutyric acid.

Authors:  Ken Madden; Wayne Clark; Nicola Lessov
Journal:  Clin Med Res       Date:  2003-04

Review 4.  Refining the Benefit/Risk Profile of Anti-Epileptic Drugs in Headache Disorders.

Authors:  Michael J Marmura; Aliza S Kumpinsky
Journal:  CNS Drugs       Date:  2018-08       Impact factor: 5.749

5.  Zonisamide decreases ethanol intake in rats and mice.

Authors:  Clifford M Knapp; Melissa Mercado; Tara Lynn Markley; Steven Crosby; Domenic A Ciraulo; Conan Kornetsky
Journal:  Pharmacol Biochem Behav       Date:  2007-04-11       Impact factor: 3.533

Review 6.  Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy.

Authors:  H D Langtry; J C Gillis; R Davis
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

Review 7.  Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.

Authors:  Richard P Shank; Bruce E Maryanoff
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

Review 8.  Topiramate: a review of its use in childhood epilepsy.

Authors:  D Ormrod; K McClellan
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.930

Review 9.  Advances on genetic rat models of epilepsy.

Authors:  Tadao Serikawa; Tomoji Mashimo; Takashi Kuramoro; Birger Voigt; Yukihiro Ohno; Masashi Sasa
Journal:  Exp Anim       Date:  2014-10-14

10.  Phenotypic Characterization of Larval Zebrafish (Danio rerio) with Partial Knockdown of the cacna1a Gene.

Authors:  Kinga Gawel; Waldemar A Turski; Wietske van der Ent; Benan J Mathai; Karolina J Kirstein-Smardzewska; Anne Simonsen; Camila V Esguerra
Journal:  Mol Neurobiol       Date:  2019-12-26       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.